World Clinical Drug
|
2026, 47(4): 441-448
• Pharmacy administration •
Trend analysis on registration and declaration of radiopharmaceuticals in China based on the National Medical Products Administration review system from 2019 to 2025
Full
Jingfei XU1, Xinyu QIAO2, Liya WEI1, Jiang YU1, Yiliang LI1, *
Affiliations
- 1.Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Tianjin 300110, China
- 2.Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
Published: 2026-04-10
doi: 10.13683/j.wph.2026.04.014
Outline
radioactive drugs
/
registration and declaration
/
drug targets
许婧菲, 乔鑫宇, 韦丽雅, 于江, 李祎亮.
基于国家药品监督管理局审评体系中国放射性药物2019—2025 年注册申报趋势分析.
世界临床药物,
2026
, 47
(4)
: 441
-448
.
DOI: 10.13683/j.wph.2026.04.014
Jingfei XU, Xinyu QIAO, Liya WEI, Jiang YU, Yiliang LI.
Trend analysis on registration and declaration of radiopharmaceuticals in China based on the National Medical Products Administration review system from 2019 to 2025[J].
World Clinical Drug,
2026
, 47
(4)
: 441
-448
.
DOI: 10.13683/j.wph.2026.04.014
Year 2026 volume 47 Issue 4
69
9
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.04.014
- Receive Date:2026-01-05
- Online Date:2026-11-05
- Published:2026-04-10